Product Details for ANDA 074823
TERAZOSIN HYDROCHLORIDE (TERAZOSIN HYDROCHLORIDE)
EQ 1MG BASE
Marketing Status: Prescription
EQ 2MG BASE
Marketing Status: Prescription
EQ 5MG BASE
Marketing Status: Prescription
EQ 10MG BASE
Marketing Status: Prescription
EQ 1MG BASE
Marketing Status: Prescription
Active Ingredient: TERAZOSIN HYDROCHLORIDE
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 1MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A074823
Product Number: 001
Approval Date: Mar 30, 1998
Applicant Holder Full Name: APNAR PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
TERAZOSIN HYDROCHLORIDE (TERAZOSIN HYDROCHLORIDE)
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 1MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A074823
Product Number: 001
Approval Date: Mar 30, 1998
Applicant Holder Full Name: APNAR PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 2MG BASE
Marketing Status: Prescription
Active Ingredient: TERAZOSIN HYDROCHLORIDE
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 2MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A074823
Product Number: 002
Approval Date: Mar 30, 1998
Applicant Holder Full Name: APNAR PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
TERAZOSIN HYDROCHLORIDE (TERAZOSIN HYDROCHLORIDE)
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 2MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A074823
Product Number: 002
Approval Date: Mar 30, 1998
Applicant Holder Full Name: APNAR PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 5MG BASE
Marketing Status: Prescription
Active Ingredient: TERAZOSIN HYDROCHLORIDE
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A074823
Product Number: 003
Approval Date: Mar 30, 1998
Applicant Holder Full Name: APNAR PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
TERAZOSIN HYDROCHLORIDE (TERAZOSIN HYDROCHLORIDE)
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A074823
Product Number: 003
Approval Date: Mar 30, 1998
Applicant Holder Full Name: APNAR PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 10MG BASE
Marketing Status: Prescription
Active Ingredient: TERAZOSIN HYDROCHLORIDE
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A074823
Product Number: 004
Approval Date: Mar 30, 1998
Applicant Holder Full Name: APNAR PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: TERAZOSIN HYDROCHLORIDE
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A074823
Product Number: 004
Approval Date: Mar 30, 1998
Applicant Holder Full Name: APNAR PHARMA LP
Marketing Status: Prescription
Patent and Exclusivity Information